Patient Management

2074 questions

Question 1341Question →

A 42-year-old woman is evaluated on hospital day 8 for discharge planning. She was admitted for a severe acute exacerbation of relapsing-remitting multiple sclerosis, which presented with rapid-onset paraparesis, sensory loss below the T10 dermatome, and urinary retention. She completed a 5-day course of high-dose intravenous methylprednisolone followed by plasma exchange. Her medical condition is now stable, and the acute neuroinflammatory process has been halted.

On current examination, she has 5/5 motor strength in her upper extremities and 2/5 strength in both lower extremities. She requires an indwelling urinary catheter. Prior to this exacerbation, she was fully independent, ambulatory, and employed full-time as a teacher. Physical and occupational therapy evaluations indicate that she requires moderate to maximal assistance for bed-to-chair transfers. She is highly motivated, has excellent rehabilitation potential, and has demonstrated the ability to actively participate in comprehensive therapy for at least 3.5 hours per day.

Which of the following is the most appropriate disposition care setting for this patient?

Show answer & explanation

Answer: Transfer to an inpatient rehabilitation facility

Answer

Transfer to an inpatient rehabilitation facility
The correct answer is transfer to an inpatient rehabilitation facility. This patient is medically stable but has severe acute functional deficits (paraparesis) requiring intensive, multidisciplinary rehabilitation (physical and occupational therapy). She meets the strict criteria for an inpatient rehabilitation facility (IRF) because she has excellent functional potential and, crucially, has demonstrated the ability to tolerate at least 3 hours of intensive therapy per day. An IRF provides this high-intensity rehab along with close medical supervision, which is standard of care for severe neuro-inflammatory exacerbations with profound reversible deficits.

Step-by-Step Solution

1
Assess the patient's current medical stability and acute care needs.
The patient has completed acute treatments (steroids, plasmapheresis) and is medically stable, indicating that acute hospitalization is no longer necessary.
Determining medical stability is the first step in safely transitioning a patient out of the acute inpatient setting.
2
Evaluate the patient's functional status and rehabilitation needs.
The patient has significant functional deficits, including paraparesis and a requirement for maximal assistance with transfers, necessitating a multidisciplinary approach.
Functional status dictates the level of nursing care and therapy required post-discharge.
3
Determine the appropriate post-acute care setting based on therapy tolerance.
The patient can tolerate and benefit from intensive therapy (>3 hours per day), making an inpatient rehabilitation facility the correct disposition.
The ability to tolerate 3 or more hours of daily multidisciplinary therapy is the primary criterion distinguishing an inpatient rehabilitation facility from a skilled nursing facility.

Key Concept

Inpatient Rehabilitation Facility (IRF) Admission Criteria
Question 1342Question →

A 52-year-old woman is hospitalized for a massive pulmonary embolism and treated with a continuous unfractionated heparin infusion. On hospital day 66, her platelet count decreases from an admission baseline of 260,000/mm3260,000/\text{mm}^3 to 85,000/mm385,000/\text{mm}^3. She subsequently reports acute left lower extremity pain, and a duplex ultrasound confirms a new deep vein thrombosis. Her clinical presentation yields a 4T score indicating a high probability of heparin-induced thrombocytopenia (HIT). Arrange the following therapeutic management and monitoring steps in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first discontinue heparin, immediately start a non-heparin anticoagulant (argatroban), monitor platelets until they recover above 150,000, then initiate warfarin, and finally stop argatroban after the INR has been therapeutic for 48 hours.
The management of HIT requires a strict multi-step de-escalation and transition protocol. All heparin must be stopped immediately to break the cycle of PF4-antibody complex formation. Because the patient is actively thrombosing, an alternative anticoagulant (e.g., argatroban, bivalirudin, or fondaparinux) must be started empirically without waiting for lab confirmation. The transition to long-term warfarin requires careful monitoring: platelets must first recover to baseline or ≥150,000/mm3\geq 150,000/\text{mm}^3 to avoid warfarin-induced skin necrosis and venous limb gangrene. Once started, warfarin must overlap with the parenteral anticoagulant for at least 55 days, and the parenteral agent is only discontinued when the INR has been therapeutic for 4848 hours.

Step-by-Step Solution

1
Discontinue heparin
Halts the ongoing formation of heparin-PF4 complexes.
Continuing heparin worsens the immune response and exacerbates thrombosis.
2
Initiate argatroban
Provides immediate, safe anticoagulation.
Patients with HIT are highly prothrombotic and require continuous anticoagulation while avoiding all heparin products.
3
Monitor platelet recovery
Confirms the HIT process is resolving.
Wait for platelets to reach at least 150,000/mm3150,000/\text{mm}^3 to ensure the hypercoagulable state is stabilizing.
4
Initiate warfarin
Begins the transition to long-term oral anticoagulation.
Starting warfarin too early (before platelet recovery) causes a precipitous drop in Protein C, paradoxically worsening hypercoagulability and risking venous limb gangrene.
5
Overlap and discontinue argatroban
Ensures uninterrupted protection against thrombosis.
Warfarin takes several days to achieve full antithrombotic effect. Argatroban must be continued until the INR is therapeutic (2.0−3.02.0-3.0) for at least 4848 hours.

Key Concept

Management and monitoring sequence of Heparin-Induced Thrombocytopenia (HIT)
Estimated Time:1m 30s
Question 1343Question →

A 2222-year-old woman is brought to the emergency department 22 hours after intentionally ingesting a large, unknown quantity of acetaminophen tablets. She is currently asymptomatic, with normal vital signs and an unremarkable physical examination. Arrange the following steps in the most appropriate chronological sequence for monitoring, evaluating, and managing this patient's overdose according to standard medical protocols.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first wait 44 hours to obtain an interpretable serum level, plot this level on the Rumack-Matthew nomogram, initiate NN-acetylcysteine if the level is above the treatment line, monitor liver chemistries serially during treatment, and finally discontinue the antidote once criteria for resolution are met.
The standard management protocol for acute acetaminophen ingestion requires establishing an accurate peak serum level to guide antidote therapy. Because acetaminophen absorption can be delayed, levels drawn before 44 hours post-ingestion are uninterpretable. Once a valid level is obtained at or after 44 hours, it must be plotted on the Rumack-Matthew nomogram to stratify the patient's risk of hepatotoxicity. If the value falls on or above the treatment line, NN-acetylcysteine (NAC) therapy is initiated to replenish hepatic glutathione stores. While on NAC, the patient requires ongoing monitoring of liver function tests (AST, ALT), coagulation (PT/INR), and renal function to evaluate for subacute hepatic injury. Finally, the treatment is evaluated for discontinuation; NAC can be safely stopped only when the patient is asymptomatic, liver enzymes are normalizing, and the serum acetaminophen level is undetectable.

Step-by-Step Solution

1
Delay initial serum level until 44 hours post-ingestion
Obtains an accurate reflection of peak absorption
Levels drawn before 44 hours are uninterpretable on the nomogram due to ongoing drug absorption.
2
Plot level on the Rumack-Matthew nomogram
Risk stratification for hepatotoxicity
Determines if the patient's toxic burden warrants antidote therapy.
3
Initiate NN-acetylcysteine (NAC)
Prevents accumulation of the toxic NAPQI metabolite
Provides a glutathione substitute to detoxify the liver if the nomogram indicates high risk.
4
Monitor serial LFTs and coagulation studies
Tracks the evolution of hepatic injury
Detects subacute hepatotoxicity that may develop despite NAC and guides ongoing treatment.
5
Discontinue NAC based on clinical and laboratory criteria
Safe conclusion of therapy
Ensures the toxic threat has completely resolved (undetectable acetaminophen and improving LFTs) before stopping the antidote.

Key Concept

Monitoring and evaluating treatment in acute acetaminophen overdose relies on delaying initial levels until peak absorption at 44 hours, using the Rumack-Matthew nomogram for risk stratification, and guiding the discontinuation of NN-acetylcysteine with serial liver function monitoring.
Estimated Time:1m 30s
Question 1344Question →

A 34-year-old woman presents to the clinic to establish primary care. She recently moved to the area and has not seen a physician in three years. She feels well and has no current symptoms. She exercises regularly, does not smoke, and consumes alcohol occasionally. Her family history is significant for a father who was diagnosed with colon cancer at age 42, and a paternal aunt who was diagnosed with breast cancer at age 60. Her mother is alive and healthy. Vital signs include a blood pressure of 118/74 mm Hg, heart rate of 70/min, and a BMI of 23 kg/m². Physical examination is unremarkable. A review of her medical records shows that a Pap smear with human papillomavirus (HPV) co-testing performed one year ago was normal, and a one-time screening for hepatitis C virus antibody was non-reactive. Which of the following is the most appropriate next step in the preventive care of this patient?

Show answer & explanation

Answer: Referral for screening colonoscopy

Answer

Referral for screening colonoscopy
The correct answer is referral for a screening colonoscopy. This patient is at high risk for colorectal cancer due to her father's diagnosis at age 42. According to guidelines from the US Multi-Society Task Force on Colorectal Cancer, individuals with a single first-degree relative diagnosed with colorectal cancer or advanced adenoma before age 60 should undergo screening colonoscopy every 5 years. This screening should begin at age 40, or 10 years younger than the earliest diagnosis in their family, whichever comes first. In this patient's case, 10 years prior to her father's diagnosis is age 32. Since she is currently 34 years old, she is overdue for screening and should be referred for a colonoscopy immediately.

Step-by-Step Solution

1
Identify the patient's risk factors for colorectal cancer.
The patient has a first-degree relative (father) diagnosed with colorectal cancer at age 42.
Family history dictates the modality and timing of colorectal cancer screening.
2
Apply the appropriate screening guideline for the identified risk level.
For a first-degree relative diagnosed before age 60, screening must start at age 40 or 10 years before the relative's age at diagnosis, whichever is earlier.
This rule ensures early detection in populations with aggressive or early-onset familial cancer patterns.
3
Calculate the indicated screening age for this specific patient.
10 years before the father's diagnosis (age 42) is age 32. Since 32 is earlier than 40, screening should begin at 32.
Determines if the patient is currently due for screening.
4
Determine the appropriate screening modality.
Colonoscopy is required; non-invasive tests like FIT are inappropriate.
High-risk patients require direct visualization to adequately assess and remove precancerous lesions.

Key Concept

Colorectal cancer screening in high-risk patients (first-degree relative diagnosed at <60 years of age) should begin with a colonoscopy at age 40 or 10 years before the relative's diagnosis, whichever is earlier.
Question 1345Question →

A 6868-year-old man is evaluated in the intensive care unit for altered mental status and uncoordinated movements. He was admitted 55 days ago for severe community-acquired pneumonia complicated by septic shock. He was intubated for 33 days and was successfully extubated yesterday. His past medical history is significant for focal impaired awareness seizures, for which he has taken oral phenytoin for the last 44 years. His current medications include intravenous ceftriaxone, subcutaneous enoxaparin, and his home dose of phenytoin, which is administered via a nasogastric tube.

On physical examination, temperature is 37.2∘37.2^{\circ} C (99.0∘99.0^{\circ} F), blood pressure is 110/70110/70 mmHg, and pulse is 8888/min. The patient is lethargic but arousable. Neurologic examination reveals prominent bilateral horizontal nystagmus, dysarthria, and severe dysmetria on finger-to-nose testing.

Serial laboratory studies over the course of his admission are shown below:

ParameterDay 1Day 3Day 5 (Today)Reference Range
Serum albumin3.53.5 g/dL2.62.6 g/dL1.91.9 g/dL3.5−5.03.5-5.0 g/dL
Blood urea nitrogen2222 mg/dL4545 mg/dL6868 mg/dL8−208-20 mg/dL
Serum creatinine1.11.1 mg/dL1.91.9 mg/dL2.82.8 mg/dL0.7−1.30.7-1.3 mg/dL
Total serum phenytoin1111 mcg/mL1313 mcg/mL1515 mcg/mL10−2010-20 mcg/mL

Which of the following is the most appropriate next step in the evaluation or management of this patient's neurologic findings?

Show answer & explanation

Answer: Obtain a serum free phenytoin concentration

Answer

Obtain a serum free phenytoin concentration to accurately assess for medication toxicity in the setting of hypoalbuminemia and acute kidney injury.
The correct answer identifies the need to measure a free phenytoin level. Phenytoin exhibits nonlinear (Michaelis-Menten) kinetics and is highly protein-bound (approximately 90%90\%). When a patient develops severe hypoalbuminemia, the number of binding sites decreases, causing the unbound, pharmacologically active fraction to rise. Furthermore, this patient has acute kidney injury; uremia alters the structural conformation of albumin, further reducing its affinity for phenytoin. Consequently, a total phenytoin level of 1515 mcg/mL in this patient masks a severely elevated free fraction that is causing his classic toxicity symptoms (nystagmus, dysmetria, lethargy). The definitive next step in monitoring is to obtain a free phenytoin concentration.

Step-by-Step Solution

1
Evaluate the clinical presentation.
The patient has new-onset lethargy, bilateral horizontal nystagmus, dysarthria, and dysmetria.
These are classic, dose-dependent signs of central nervous system toxicity from phenytoin.
2
Analyze the laboratory trends in the context of the medication.
Total phenytoin is 1515 mcg/mL (therapeutic range 10−2010-20 mcg/mL). However, albumin has dropped significantly to 1.91.9 g/dL, and the patient has developed acute kidney injury with uremia (BUN 6868 mg/dL).
Phenytoin is normally 90%90\% bound to albumin. Hypoalbuminemia means there are fewer binding sites, and uremia alters the affinity of existing albumin, both leading to an increased free (unbound, active) fraction of the drug.
3
Determine the appropriate management step.
Order a serum free phenytoin concentration.
Because the total level is misleadingly 'normal', evaluating the free fraction (target 1−21-2 mcg/mL) will confirm the suspected toxicity and guide dosage adjustments.

Key Concept

In patients with severe hypoalbuminemia or uremia, total serum phenytoin levels are an inaccurate measure of pharmacologic activity because the unbound (free) fraction of the drug increases significantly, necessitating the measurement of free phenytoin levels to diagnose toxicity.

Alternative Method

Instead of waiting for a free phenytoin lab result (which is a send-out test at many institutions), clinicians can mathematically estimate the adjusted total phenytoin level using the Winter-Tozer equation. For patients with renal failure, the formula is: Adjusted Total Phenytoin = Measured Total / ((0.1 * Albumin) + 0.1). For this patient, the estimated adjusted total level would be 15/((0.1∗1.9)+0.1)=15/0.29≈51.715 / ((0.1 * 1.9) + 0.1) = 15 / 0.29 \approx 51.7 mcg/mL, which massively exceeds the therapeutic upper limit of 2020 mcg/mL.
Estimated Time:1m 30s
Question 1346Question →

A 71-year-old man is admitted to the intensive care unit with a 3-day history of worsening confusion, severe weakness, and diffuse abdominal pain with constipation. He has a history of squamous cell carcinoma of the lung with diffuse metastases to the ribs and thoracic spine. The patient has been unable to drink fluids for the past 2 days due to profound nausea. Vital signs show temperature 37.2∘C37.2^\circ\text{C}, heart rate 118/min118\text{/min}, blood pressure 92/58 mmHg92/58\text{ mmHg}, and respiratory rate 18/min18\text{/min}. Physical examination reveals a somnolent patient who withdraws from painful stimuli. His mucous membranes are extremely dry, and skin turgor is significantly decreased.

Initial laboratory studies reveal:
Serum sodium: 148 mEq/L148\text{ mEq/L}
Serum potassium: 4.2 mEq/L4.2\text{ mEq/L}
Serum chloride: 106 mEq/L106\text{ mEq/L}
Serum bicarbonate: 24 mEq/L24\text{ mEq/L}
Blood urea nitrogen: 82 mg/dL82\text{ mg/dL}
Serum creatinine: 4.8 mg/dL4.8\text{ mg/dL} (baseline 1.2 mg/dL1.2\text{ mg/dL})
Serum total calcium: 16.2 mg/dL16.2\text{ mg/dL}
Serum albumin: 3.0 mg/dL3.0\text{ mg/dL}
Serum phosphorus: 2.1 mg/dL2.1\text{ mg/dL}

Aggressive intravenous hydration with 0.9%0.9\% normal saline and administration of subcutaneous calcitonin are immediately initiated. Which of the following is the most appropriate additional pharmacologic intervention to provide sustained control of this patient's hypercalcemia?

Show answer & explanation

Answer: Subcutaneous denosumab

Answer

Subcutaneous denosumab is the most appropriate intervention for sustained calcium control because it is not nephrotoxic and can be safely used in the setting of severe acute kidney injury.
The correct answer is subcutaneous denosumab. This patient presents with severe hypercalcemia of malignancy (HCM) and a superimposed acute kidney injury (AKI). The immediate management of severe HCM requires aggressive intravenous isotonic fluid resuscitation to restore intravascular volume and calcitonin for a rapid decline in serum calcium. Because calcitonin's effect is transient (tachyphylaxis occurs within 48 hours), a long-acting bone resorption inhibitor must be administered concurrently. While intravenous bisphosphonates are traditionally first-line for sustained control, they are highly nephrotoxic and contraindicated in patients with severe renal impairment (e.g., serum creatinine >4.5 mg/dL> 4.5\text{ mg/dL} or CrCl <30 mL/min< 30\text{ mL/min}). Denosumab is a monoclonal antibody that binds to the receptor activator of nuclear factor kappa-B ligand (RANKL), preventing osteoclast activation. It is not cleared by the kidneys, lacks nephrotoxicity, and is the preferred guideline-supported agent for long-term calcium control in HCM patients with severe AKI.

Step-by-Step Solution

1
Determine the severity and etiology of the metabolic derangement.
The patient has severe hypercalcemia of malignancy (corrected calcium = 17.0 mg/dL) driven by squamous cell carcinoma (likely PTHrP-mediated or due to osteolytic bone metastases).
Corrected calcium >14 mg/dL> 14\text{ mg/dL} is a life-threatening emergency requiring immediate multi-modal treatment.
2
Evaluate the patient's renal function based on laboratory values.
The patient has a severe acute kidney injury (AKI) with a serum creatinine of 4.8 mg/dL4.8\text{ mg/dL} (baseline 1.2 mg/dL1.2\text{ mg/dL}), likely prerenal from hypercalcemia-induced nephrogenic diabetes insipidus and poor oral intake.
Renal function strictly dictates which long-term calcium-lowering pharmacotherapies can be safely administered.
3
Select the appropriate class of medication for sustained calcium control.
A long-acting bone resorption inhibitor must be administered concurrently with rapid-acting agents (fluids and calcitonin).
Calcitonin acts rapidly but exhibits tachyphylaxis within 48 hours, requiring a long-term agent to maintain normocalcemia.
4
Differentiate between available bone resorption inhibitors based on the patient's AKI.
Intravenous bisphosphonates (e.g., zoledronic acid) are contraindicated due to severe nephrotoxicity. Denosumab (a monoclonal antibody against RANKL) is selected.
Denosumab is cleared via the reticuloendothelial system rather than the kidneys, making it the safest and most effective choice for patients with severe renal impairment.

Key Concept

In patients with severe hypercalcemia of malignancy complicated by severe renal impairment (e.g., severe AKI or CrCl <30 mL/min< 30\text{ mL/min}), denosumab is the preferred long-acting bone resorption inhibitor over bisphosphonates, which are nephrotoxic and contraindicated.
Question 1347Question →

During a routine follow-up appointment, a 3434-year-old female is evaluated for persistently elevated blood pressure. She was diagnosed with hypertension six months ago and is currently adherent to a regimen of maximum-dose amlodipine, chlorthalidone, and lisinopril. Despite this therapy, her home blood pressure readings consistently range from 160/100160/100 to 175/110 mm Hg175/110 \text{ mm Hg}. The patient mentions occasional mild headaches but otherwise feels well. She does not smoke or consume alcohol. Family history is notable for hypertension in her father, diagnosed at age 5555.

Vital signs in the office today show a blood pressure of 168/104 mm Hg168/104 \text{ mm Hg} and a heart rate of 76/min76/\text{min}. Physical examination reveals a thin adult with a body mass index of 22 kg/m222 \text{ kg/m}^2. Cardiopulmonary examination is unremarkable. Auscultation of the abdomen reveals a soft, high-pitched systolic bruit over the right upper quadrant.

Laboratory studies are obtained and compared to baseline values from three weeks ago, just prior to the addition of lisinopril to her regimen:

Laboratory ParameterCurrent ValueBaseline (3 weeks ago)
Serum sodium139 mEq/L139 \text{ mEq/L}140 mEq/L140 \text{ mEq/L}
Serum potassium4.1 mEq/L4.1 \text{ mEq/L}4.0 mEq/L4.0 \text{ mEq/L}
Serum creatinine1.8 mg/dL1.8 \text{ mg/dL}0.9 mg/dL0.9 \text{ mg/dL}
Blood urea nitrogen24 mg/dL24 \text{ mg/dL}12 mg/dL12 \text{ mg/dL}

Which of the following is the most appropriate next step in the diagnostic workup?

Show answer & explanation

Answer: Renal duplex ultrasonography

Answer

Renal duplex ultrasonography
The correct approach for a patient with high clinical suspicion for renovascular hypertension (indicated by young age, resistant hypertension, an abdominal bruit, and an ACE inhibitor-induced acute kidney injury) is to perform non-invasive vascular imaging. Because this patient has a significantly elevated serum creatinine (1.8 mg/dL1.8 \text{ mg/dL}), tests requiring iodinated contrast pose a high risk of contrast-induced nephropathy. Renal duplex ultrasonography provides excellent sensitivity for detecting renal artery stenosis without utilizing nephrotoxic agents, making it the ideal initial test in this diagnostic sequence.

Step-by-Step Solution

1
Analyze the clinical presentation and identify the underlying syndrome.
The patient is a young female with resistant hypertension, an abdominal bruit, and an acute doubling of serum creatinine after starting an ACE inhibitor (lisinopril).
This constellation of findings is highly specific for bilateral renal artery stenosis or severe unilateral stenosis, likely due to fibromuscular dysplasia in this demographic.
2
Evaluate the current physiological state to guide safe test selection.
The patient has acute kidney injury, evidenced by the jump in serum creatinine from 0.9 mg/dL0.9 \text{ mg/dL} to 1.8 mg/dL1.8 \text{ mg/dL}.
Recognizing the acute kidney injury is critical because it dictates which imaging modalities are safe to use.
3
Determine the optimal sequence for diagnostic imaging.
Renal duplex ultrasonography is selected as the next step.
It is a highly sensitive and specific non-invasive screening tool that does not utilize nephrotoxic iodinated contrast or gadolinium, making it the safest initial test for a patient with compromised renal function.

Key Concept

In patients with suspected renovascular hypertension and impaired renal function (such as an ACE inhibitor-induced acute kidney injury), renal duplex ultrasonography is the preferred initial diagnostic imaging modality because it avoids the risk of contrast-induced nephropathy associated with CTA.
Estimated Time:1m 15s
Question 1348Question →

A 2727-year-old man presents to the emergency department with a 55-day history of abdominal pain. The pain initially began around his umbilicus and was associated with nausea and two episodes of nonbloody emesis. Three days ago, the pain migrated to the right lower quadrant and became more constant. Yesterday, he felt slightly better, but today he developed a fever and worsening, severe right lower quadrant pain. Temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 122/78 mmHg122/78\text{ mmHg}, pulse is 112/min112/\text{min}, and respirations are 18/min18/\text{min}. Physical examination reveals a palpable, tender, 6 cm6\text{ cm} mass in the right lower quadrant. Bowel sounds are hypoactive. Laboratory studies show a leukocyte count of 17,200/mm317,200/\text{mm}^3 with a neutrophil predominance. Computed tomography of the abdomen and pelvis with intravenous contrast reveals a ruptured appendix with an adjacent 5.2 cm5.2\text{ cm} rim-enhancing periappendiceal fluid collection. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intravenous antibiotics and percutaneous fluid drainage

Answer

Intravenous antibiotics and percutaneous fluid drainage
The correct approach to a patient presenting with appendicitis symptoms for more than 55 days and a confirmed abscess larger than 3 cm3\text{ cm} is nonoperative management with intravenous antibiotics and percutaneous image-guided drainage. In delayed presentations, the body has walled off the perforation, creating a mass of inflamed tissue and adherent bowel loops (phlegmon or abscess). Attempting an immediate appendectomy in this setting is technically difficult and carries a high complication rate, including iatrogenic enterotomy and the unintended need for an ileocecectomy or right hemicolectomy. After successful percutaneous drainage and resolution of the acute infection, the patient can be evaluated for an elective interval appendectomy several weeks later.

Step-by-Step Solution

1
Analyze the clinical presentation and timeline.
The patient has a 55-day history of RLQ pain, fever, tachycardia, and a palpable mass, suggesting a delayed presentation of appendicitis with complication.
Establishing the timeline of appendicitis is critical, as management changes significantly if symptoms have been present for >5>5 days.
2
Interpret the imaging findings.
CT scan confirms a ruptured appendix with a 5.2 cm5.2\text{ cm} abscess.
Fluid collections >3 cm>3\text{ cm} require different management than small phlegmons or early, uncomplicated appendicitis.
3
Select the appropriate procedural intervention.
Choose percutaneous CT-guided drainage combined with IV antibiotics over immediate surgery.
Immediate surgery in the setting of a large, late-presenting abscess carries a high risk of bowel injury and the need for ileocecal resection due to severe inflammation.

Key Concept

Management of late-presentation appendiceal abscess
Estimated Time:1m 0s
Question 1349Question →

A 58-year-old man with a history of stage 4 chronic kidney disease and heart failure is brought to the emergency department due to profound generalized muscle weakness and palpitations that began earlier today. His medications include lisinopril and newly prescribed spironolactone. His heart rate is 54/min, and blood pressure is 112/68 mmHg. An electrocardiogram reveals widened QRS complexes merging with tall, peaked T waves in a "sine wave" pattern. A point-of-care basic metabolic panel shows a serum potassium level of 8.4 mEq/L.

Arrange the following pharmacologic interventions in the most appropriate chronological sequence for the acute management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of administration is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and 50% dextrose, 3) Oral sodium zirconium cyclosilicate.
The fundamental algorithm for severe hyperkalemia with electrocardiographic changes dictates a strict temporal sequence based on the onset of action of each pharmacologic agent. First, myocardial cell membranes must be stabilized to prevent lethal arrhythmias, which is achieved rapidly (1-3 minutes) with intravenous calcium gluconate. Second, potassium must be temporarily redistributed into the intracellular compartment using intravenous regular insulin (accompanied by dextrose to prevent hypoglycemia); this process takes 15-30 minutes. Finally, total body potassium must be definitively reduced using gastrointestinal potassium binders such as sodium zirconium cyclosilicate, which have an onset of several hours. Proceeding in any other order leaves the patient vulnerable to sudden cardiac death.

Step-by-Step Solution

1
Identify the life-threatening emergency.
The patient has severe hyperkalemia (8.4 mEq/L) with critical ECG changes (widened QRS, sine wave pattern).
Recognizing sine wave morphology indicates impending cardiac arrest, necessitating immediate step-wise intervention.
2
Prioritize myocardial stabilization.
Select intravenous calcium gluconate as the immediate first intervention.
Calcium directly antagonizes the membrane actions of hyperkalemia. It restores the resting membrane potential difference, taking effect in 1-3 minutes to prevent fatal arrhythmias.
3
Initiate temporary potassium shifting.
Select intravenous regular insulin (with dextrose to prevent hypoglycemia) as the second intervention.
Once the heart is temporarily protected, serum potassium must be rapidly lowered. Insulin drives potassium into cells via Na+/K+-ATPase activation, acting within 15-30 minutes.
4
Establish definitive potassium removal.
Select oral sodium zirconium cyclosilicate as the final pharmacologic step in this sequence.
Calcium and insulin are temporary measures. A potassium binder removes total body potassium through the gastrointestinal tract, providing definitive but slower (hours) treatment.

Key Concept

The sequential management of severe hyperkalemia involves three distinct phases: immediate myocardial stabilization (calcium), rapid intracellular shifting (insulin/glucose), and definitive total body removal (cation exchange resins or loop diuretics).
Question 1350Question →

A 5858-year-old man is brought to the emergency department by his husband due to severe, worsening mid-back pain over the past week. The patient has a history of type 2 diabetes mellitus and intravenous substance use. Over the last 1212 hours, he has developed profound weakness in both legs and has been unable to urinate. His temperature is 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}), blood pressure is 118/76 mm Hg118/76\text{ mm Hg}, pulse is 108/min108/\text{min}, and respirations are 18/min18/\text{min}. Physical examination reveals marked tenderness to percussion over the midthoracic spine. Neurological examination shows 3/53/5 muscle strength in the bilateral lower extremities, decreased sensation to pinprick below the umbilicus, and hyperreflexia at the patellae with bilateral upgoing plantar reflexes. Digital rectal examination demonstrates decreased anal sphincter tone. Which of the following are the most appropriate immediate steps in this patient's diagnostic workup? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Urgent magnetic resonance imaging of the entire spine with gadolinium; Blood cultures from two separate peripheral sites

Answer

The correct diagnostic steps are urgent magnetic resonance imaging of the entire spine with gadolinium and blood cultures from two separate peripheral sites.
This patient's acute presentation of severe back pain, fever, and signs of spinal cord compression (lower extremity weakness, sensory level, bowel/bladder dysfunction, and hyperreflexia) in the setting of intravenous substance use is highly suspicious for a spinal epidural abscess (SEA). SEA is a neurosurgical emergency. The initial diagnostic workup must rapidly establish the anatomic extent of the disease and the causative organism without causing harm. Urgent magnetic resonance imaging (MRI) of the entire spine with gadolinium is the gold standard diagnostic test to visualize the epidural collection and the severity of cord compression. Concurrently, blood cultures must be drawn from two separate sites to identify the pathogen and allow for appropriately targeted long-term intravenous antibiotic therapy.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the patient's presentation.
The patient demonstrates the classic triad for a spinal epidural abscess (SEA): severe focal back pain, fever, and progressive neurological deficits (leg weakness, sensory level, urinary retention, and upper motor neuron signs).
Recognizing this neurological emergency is critical to prevent permanent paralysis and dictates immediate diagnostic sequencing.
2
Determine the optimal neuroimaging modality.
Urgent magnetic resonance imaging (MRI) of the spine with contrast is selected.
MRI is the most sensitive and specific test for diagnosing SEA, evaluating the exact location and size of the abscess, and assessing the degree of spinal cord compression to guide surgical decompression.
3
Select the appropriate initial laboratory workup for identifying the etiology.
Blood cultures from two separate venipuncture sites are selected.
Identifying the microbiologic cause (most commonly Staphylococcus aureus) is essential for tailoring long-term antibiotic therapy. Blood cultures are positive in approximately 60% of cases and must be drawn before initiating empiric antibiotics.

Key Concept

Patients presenting with signs of a spinal epidural abscess with cord compression require an immediate diagnostic workup consisting of an urgent spinal MRI with contrast and concurrent peripheral blood cultures to facilitate rapid neurosurgical intervention and targeted antimicrobial therapy.
Question 1351Question →

Paramedics transport an elderly female resident of an assisted living facility to the acute care unit. Staff at the facility reported she had been complaining of unremitting abdominal discomfort and had vomited several times over the prior half-day. She is 7272 years old. Her documented medical history is significant for chronic hypertension, paroxysmal atrial fibrillation, and a history of an open cholecystectomy a decade ago. Vital signs upon triage show a temperature of 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), a blood pressure of 85/50 mm Hg85/50\text{ mm Hg}, a heart rate of 128/min128/\text{min}, and a respiratory rate of 24/min24/\text{min}. Her abdomen is markedly distended. Palpation elicits diffuse guarding and rebound tenderness across all quadrants. Auscultation reveals a silent abdomen. Close inspection of the right lower quadrant demonstrates a prominent, non-reducible mass adjacent to her prior surgical scar. The skin overlying the mass is notably erythematous, warm to the touch, and exquisitely painful upon minimal contact. Which of the following interventions are indicated for this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Intravenous crystalloid resuscitation; Broad-spectrum intravenous antibiotics; Emergent surgical exploration

Answer

The correct steps are intravenous crystalloid resuscitation, broad-spectrum intravenous antibiotics, and emergent surgical exploration.
The clinical presentation is highly indicative of a strangulated incisional hernia complicated by bowel ischemia or perforation. This is evidenced by the exquisitely tender, erythematous hernia sac, absent bowel sounds, diffuse peritonitis, and signs of septic shock. In this scenario, the standard of care is immediate concurrent resuscitation with intravenous fluids and broad-spectrum antibiotics, followed immediately by definitive procedural intervention via emergent surgical exploration. Delaying surgery for imaging or attempting manual reduction can be fatal.

Step-by-Step Solution

1
Assess the patient's hemodynamic status and vital signs.
The patient is hypotensive, tachycardic, and febrile, which indicates the presence of septic shock.
Recognizing hemodynamic instability prioritizes immediate resuscitation over diagnostic testing.
2
Evaluate the localized and systemic physical examination findings.
The patient has a tender, erythematous right lower quadrant mass near a surgical scar, accompanied by diffuse peritonitis.
These findings are diagnostic for a strangulated incisional hernia with resulting bowel ischemia.
3
Determine the appropriate combination of interventions.
The patient requires immediate fluid resuscitation, broad-spectrum antibiotics, and direct transfer to the operating room.
Definitive surgical intervention is life-saving; delaying for imaging or attempting reduction are dangerous missteps.

Key Concept

In patients with a strangulated hernia and peritonitis, immediate management requires concurrent hemodynamic resuscitation, broad-spectrum antibiotics, and emergent surgical exploration.
Estimated Time:1m 30s
Question 1352Question →

A 26-year-old man with a known history of ulcerative colitis is admitted to the hospital with an acute flare. He reports 10 to 12 bloody bowel movements daily and severe lower abdominal pain. His temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), blood pressure is 110/70 mm Hg110/70 \text{ mm Hg}, and heart rate is 118/min118/min. Laboratory results show a hemoglobin of 9.8 g/dL9.8 \text{ g/dL}, leukocyte count of 14,000/μL14,000/\mu\text{L}, and C-reactive protein (CRP) of 90 mg/L90 \text{ mg/L}. A diagnosis of acute severe ulcerative colitis (ASUC) is made.

Arrange the following steps in the standard evidence-based chronological sequence for the therapeutic management and monitoring of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The standard sequence is: rule out infections and start IV steroids, monitor closely for acute complications like toxic megacolon, formally evaluate the treatment response on days 3 to 5, escalate to medical rescue therapy if steroid-refractory, and finally de-escalate to an oral taper once clinical remission is achieved.
The standard evidence-based protocol for acute severe ulcerative colitis (ASUC) relies on a stepwise escalation and de-escalation framework centered around rigorous monitoring and treatment evaluation. It begins with ruling out superimposed infections and immediately initiating high-dose IV corticosteroids. Because ASUC carries a high short-term complication rate, intensive daily monitoring for toxic megacolon is crucial during the early stages of therapy. The hallmark of ASUC management is the mandatory treatment evaluation between hospital days 3 and 5 (using indices like the Oxford criteria, which rely on stool frequency and CRP). If the patient is determined to be steroid-refractory at this specific interval, the standard of care dictates immediate escalation to medical rescue therapy (infliximab or cyclosporine) or surgical colectomy. Finally, only after achieving clinical stability and remission, the patient is transitioned to an oral steroid taper alongside long-term maintenance therapy.

Step-by-Step Solution

1
Exclude infection and start initial induction therapy
The patient begins intravenous corticosteroid therapy safely without exacerbating a hidden infection.
Enteric infections can trigger flares and complicate immunosuppression. IV steroids remain the first-line gold standard for ASUC induction.
2
Conduct rigorous daily clinical monitoring
The patient is closely monitored for colonic dilation, systemic toxicity, and deterioration.
Patients receiving initial high-dose steroids are at the highest risk for acute complications like toxic megacolon during the first 72 hours.
3
Evaluate treatment efficacy at the required interval
The clinical trajectory is objectively assessed on hospital days 3 to 5 using markers like CRP and daily stool frequency.
Evidence-based guidelines mandate a formal assessment at 72 to 120 hours to identify non-responders and prevent the risks of prolonged, ineffective steroid exposure.
4
Escalate to rescue therapy if indicated
Rescue medical therapy (e.g., infliximab) or surgical intervention is implemented.
Failure to meet objective response criteria by day 5 signifies steroid-refractory disease, requiring immediate escalation to alter the disease course.
5
De-escalate to outpatient maintenance therapy
The patient is transitioned to oral corticosteroids with a tapering plan and a long-term maintenance drug.
After the acute flare is resolved, management shifts to maintaining remission and minimizing the adverse effects of chronic corticosteroid use.

Key Concept

The management of acute severe ulcerative colitis follows a highly structured sequence: initial IV corticosteroids, rigorous complication monitoring, mandatory objective response evaluation between days 3 and 5, escalation to rescue therapy if refractory, and eventual transition to an oral taper for maintenance.
Question 1353Question →

A 4242-year-old man is brought to the emergency department after a high-speed motorcycle crash. He is agitated, pale, and diaphoretic. His temperature is 36.2∘C36.2^\circ C, heart rate is 142/min142/min, blood pressure is 76/4076/40 mmHg, and respiratory rate is 28/min28/min. The airway is patent, and breath sounds are present and equal bilaterally. A cervical spine collar is in place. The abdomen is grossly distended and rigid, with diffuse tenderness to palpation. The pelvis is mechanically stable to anterior-posterior and lateral compression. Bedside focused assessment with sonography for trauma (FAST) demonstrates a large amount of anechoic fluid in the hepatorenal and splenorenal recesses. Two large-bore intravenous lines are placed, and balanced crystalloid resuscitation is initiated alongside an uncrossmatched blood transfusion. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Immediate exploratory laparotomy

Answer

Immediate exploratory laparotomy
The correct answer is immediate exploratory laparotomy. In the algorithm for blunt abdominal trauma, any patient who presents with hemodynamic instability (e.g., severe hypotension and tachycardia) and has a positive FAST exam is presumed to have a life-threatening intra-abdominal hemorrhage. These patients must be transported immediately to the operating room for surgical exploration to arrest the bleeding. Resuscitation with blood products should occur simultaneously with surgical control.

Step-by-Step Solution

1
Assess the patient's hemodynamic status.
The patient is in class III/IV hemorrhagic shock, evidenced by severe hypotension (76/4076/40 mmHg) and significant tachycardia (142/min142/min).
Identifying hemodynamic instability dictates whether the patient can safely undergo time-consuming imaging or requires immediate resuscitation and surgery.
2
Evaluate the primary source of hemorrhage using adjuncts like the FAST exam.
The FAST exam is positive, showing anechoic fluid (blood) in the dependent spaces of the abdominal cavity.
In the setting of blunt trauma, a positive FAST rapidly confirms the abdomen as the source of life-threatening hemorrhage.
3
Determine the definitive treatment setting.
The combination of hemodynamic instability and confirmed intraperitoneal hemorrhage mandates surgical exploration.
Non-operative management or advanced imaging is strictly reserved for hemodynamically stable patients.

Key Concept

Hemodynamically unstable patients with blunt abdominal trauma and a positive FAST exam require emergent exploratory laparotomy.
Estimated Time:1m 0s
Question 1354Question →

A multidisciplinary rounding team is determining the optimal discharge pathway for a 78-year-old man who has been hospitalized for six days due to methicillin-resistant *Staphylococcus aureus* bacteremia secondary to a cellulitis infection. He has been afebrile for 48 hours, and repeat blood cultures show no growth. Vital signs are normal, except for a heart rate of 92/min. Laboratory studies show a white blood cell count of 11,200/mm311,200/\mathrm{mm}^3 (down from 18,500/mm318,500/\mathrm{mm}^3 on admission) and a serum creatinine of 1.3 mg/dL1.3\text{ mg/dL} (baseline 1.2 mg/dL1.2\text{ mg/dL}). The infectious disease service recommends an additional four weeks of intravenous vancomycin. Prior to admission, the patient lived alone and was completely independent. Currently, due to profound deconditioning, he requires moderate assistance with bed-to-chair transfers and ambulates less than 10 feet with a walker. Therapy evaluations note that he fatigues rapidly, tolerating a maximum of 45 minutes of active physical and occupational therapy per day. His nearest relative lives in another state. Which of the following is the most appropriate care setting transition for this patient?

Show answer & explanation

Answer: Skilled nursing facility

Answer

Skilled nursing facility
The correct answer identifies a skilled nursing facility as the optimal care setting. This patient is hemodynamically stable and no longer requires acute medical-surgical hospital care, but he needs ongoing skilled nursing care (intravenous antibiotics) and rehabilitation (physical therapy for profound deconditioning). Because he can only tolerate 45 minutes of therapy per day and requires assistance with transfers while living alone without a caregiver, a skilled nursing facility is the safest and most appropriate disposition. These facilities provide subacute medical care alongside lower-intensity rehabilitation typically ranging from 1 to 2 hours per day.

Step-by-Step Solution

1
Evaluate the patient's ongoing medical and nursing requirements.
The patient needs an additional 4 weeks of intravenous vancomycin.
Intravenous medication administration requires skilled nursing oversight, which dictates the baseline level of care required outside of an acute hospital.
2
Assess the patient's functional status, rehabilitation capacity, and social support.
The patient requires moderate assistance with transfers, tolerates only 45 minutes of therapy per day, and lives entirely alone.
Functional capacity and home support determine whether the patient can safely return home or must transition to an inpatient post-acute care setting (and at what intensity).
3
Synthesize the data to match the patient with the correct facility criteria.
A skilled nursing facility is chosen over home, an inpatient rehabilitation facility, or a long-term acute care hospital.
A skilled nursing facility provides the required IV antibiotic administration, custodial assistance with transfers, and a lower-intensity rehabilitation program suited to a patient who fatigues quickly.

Key Concept

Disposition to post-acute care settings requires matching a patient's medical acuity (e.g., IV antibiotics), rehabilitation endurance (ability to tolerate therapy), and social support structure (home safety) to specific facility admission criteria.
Question 1355Question →

A 29-year-old woman is brought to the emergency department by her husband due to severe agitation, confusion, and palpitations that began earlier today. Her husband reports she has been increasingly irritable and has had profuse sweating and watery diarrhea for the past two days. She was diagnosed with a thyroid disorder three years ago but stopped taking her medications six months ago.

Vital signs are temperature 39.8°C (103.6°F), blood pressure 160/90 mm Hg, pulse 155/min and irregularly irregular, and respirations 24/min. Physical examination reveals a distressed, diaphoretic woman. A diffuse, non-tender goiter is palpable. Eye examination shows mild exophthalmos and lid retraction. Neurologic examination is notable for a fine resting tremor and brisk deep tendon reflexes. Electrocardiogram confirms atrial fibrillation with a rapid ventricular response. The patient's clinical presentation is highly consistent with a life-threatening endocrine emergency.

Which of the following pharmacologic interventions should be administered simultaneously as part of the immediate, initial therapeutic regimen? (Select 3)

Select all that apply

Show answer & explanation

Answer: Intravenous propranolol; Oral propylthiouracil; Intravenous hydrocortisone

Answer

The correct interventions are intravenous propranolol, oral propylthiouracil, and intravenous hydrocortisone.
The correct immediate bundle consists of intravenous propranolol, oral propylthiouracil, and intravenous hydrocortisone. Propranolol rapidly controls adrenergic symptoms and blocks peripheral T4 to T3 conversion. Propylthiouracil blocks de novo thyroid hormone synthesis and also blocks peripheral conversion. Hydrocortisone further inhibits peripheral conversion and treats the relative adrenal insufficiency often precipitated by the hypermetabolic state of thyroid storm. These three agents must be given simultaneously upon recognition of the syndrome.

Step-by-Step Solution

1
Identify the clinical syndrome based on the patient's presentation.
The combination of hyperpyrexia, severe tachycardia, agitation, goiter, exophthalmos, and GI distress points to thyroid storm.
Recognizing this life-threatening endocrine emergency is required to initiate the specific, rapid-acting multi-drug protocol.
2
Determine the therapeutic goals of immediate pharmacologic management.
The immediate goals are blocking peripheral adrenergic effects, halting new hormone synthesis, and preventing peripheral conversion of T4 to T3.
These mechanisms collectively blunt the systemic toxicity of excess thyroid hormone as quickly as possible.
3
Select the medications that achieve these goals safely while avoiding contraindicated agents.
Propranolol, propylthiouracil, and hydrocortisone fulfill these criteria and are given immediately. Potassium iodide and amiodarone are withheld.
Simultaneous administration of these three agents maximizes the blockade of hormone synthesis and effect while respecting the physiologic contraindications of early iodine administration.

Key Concept

The immediate multimodal pharmacologic management of thyroid storm requires simultaneous administration of a beta-blocker, a thionamide, and a glucocorticoid, while strictly delaying iodine therapy.
Question 1356Question →

A 6868-year-old woman is brought to the emergency department from a skilled nursing facility due to altered mental status and fever. Her temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 74/42 mm Hg74/42\text{ mm Hg}, pulse is 128/min128/\text{min}, and respiratory rate is 24/min24/\text{min}. Oxygen saturation is 94%94\% on room air. Physical examination reveals dry mucous membranes and cloudy, malodorous urine in her Foley catheter. Laboratory studies show a leukocyte count of 18,500/mm318,500/\text{mm}^3 and a serum lactate level of 6.2 mmol/L6.2\text{ mmol/L}. Blood and urine cultures are obtained, and broad-spectrum intravenous antibiotics are initiated.

Assuming the patient's hemodynamic instability persists despite each consecutive intervention, arrange the following therapies in the correct guideline-concordant sequence for the escalating management of her septic shock.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for escalating pharmacologic therapy in septic shock is: 1) Intravenous rapid crystalloid bolus, 2) Continuous intravenous norepinephrine infusion, 3) Continuous intravenous vasopressin infusion, 4) Intravenous hydrocortisone.
The standard protocol for escalating hemodynamic support in septic shock involves a highly specific sequence designed to optimize perfusion while minimizing drug toxicity. After securing source control and administering broad-spectrum antibiotics, hemodynamic resuscitation must always begin with a rapid fluid bolus of 30 mL/kg30\text{ mL/kg} of crystalloids. This corrects the relative hypovolemia induced by systemic inflammatory vasodilation. If the mean arterial pressure (MAP) fails to stabilize at ≥65 mm Hg\geq 65\text{ mm Hg} after adequate volume expansion, continuous intravenous norepinephrine is established as the first-line vasopressor. If hypotension persists despite escalating doses of norepinephrine, vasopressin is added as a second-line agent; this capitalizes on an alternative receptor pathway (V1V_1 receptors) to augment MAP while sparing the patient from the profound ischemic and arrhythmogenic side effects of high-dose catecholamines. Finally, if the patient remains hemodynamically unstable despite adequate fluids and dual vasopressor therapy, intravenous hydrocortisone is administered to treat potential relative adrenal insufficiency and upregulate vascular adrenergic receptors.

Step-by-Step Solution

1
Recognize septic shock and initiate fluid resuscitation.
Administer 30 mL/kg of intravenous balanced crystalloids.
Hypovolemia resulting from profound vasodilation and capillary leak must be corrected first to optimize cardiac preload before utilizing vasoactive agents.
2
Assess hemodynamic response to fluids; if mean arterial pressure (MAP) remains below 65 mm Hg, start a first-line vasopressor.
Initiate continuous intravenous norepinephrine.
Norepinephrine is the vasopressor of choice in septic shock due to its strong alpha-1 agonist properties, effectively increasing systemic vascular resistance with modest beta-1 inotropic support.
3
Evaluate response to primary vasopressor therapy; if MAP remains inadequate or high doses are required, escalate with a second-line pressor.
Add continuous intravenous vasopressin.
Relative vasopressin deficiency can occur in severe sepsis. Adding vasopressin helps achieve target blood pressure while simultaneously providing a catecholamine-sparing effect to reduce norepinephrine toxicity.
4
Identify refractory shock requiring multiple or escalating vasopressors.
Administer intravenous hydrocortisone.
Corticosteroids address critical illness-related corticosteroid insufficiency (CIRCI) and sensitize the vasculature to endogenous and exogenous catecholamines. They are reserved for fluid- and vasopressor-refractory shock.

Key Concept

The management of septic shock follows a strict algorithmic escalation: adequate volume resuscitation with crystalloids, followed by norepinephrine as the first-line vasopressor, the addition of vasopressin for refractory hypotension or catecholamine-sparing, and finally intravenous corticosteroids for persistent vasopressor-refractory shock.
Question 1357Question →

A 7878-year-old man is evaluated for discharge planning. He was admitted one week ago for fever and severe localized lower back pain and was subsequently diagnosed with methicillin-susceptible *Staphylococcus aureus* (MSSA) vertebral osteomyelitis of L3-L4. He has been treated with intravenous cefazolin. He is now afebrile, hemodynamically stable, and his back pain has significantly improved. He requires an additional five weeks of intravenous antibiotic therapy. His medical history is significant for hypertension and moderate Alzheimer dementia. Prior to admission, he lived alone, and his son visited on weekends to help with chores. The patient is able to ambulate independently with a cane, which is his baseline, and is independent in basic activities of daily living such as eating and dressing. However, he is oriented only to person, has significant short-term memory deficits, and requires supervision for medication administration. Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Transfer to a skilled nursing facility

Answer

The most appropriate disposition is transfer to a skilled nursing facility.
This patient requires five more weeks of intravenous antibiotics for vertebral osteomyelitis. Although he is medically stable for discharge from the acute care hospital, his moderate Alzheimer dementia and living situation (living alone with limited support) make a discharge home with outpatient parenteral antimicrobial therapy (OPAT) unsafe. He requires daily skilled nursing care for intravenous medication administration and monitoring, which is appropriately provided in a skilled nursing facility.

Step-by-Step Solution

1
Assess the patient's ongoing medical needs.
The patient requires five more weeks of intravenous antibiotics for vertebral osteomyelitis.
Determines the level of skilled care required.
2
Evaluate the patient's functional and cognitive status.
He is at his physical baseline but has moderate dementia with short-term memory deficits.
Determines rehabilitation needs and capacity for self-care.
3
Assess the patient's social support and home environment.
He lives alone with only weekend visits from family.
Determines if home discharge is safe.
4
Match the combined needs to the appropriate care setting.
Skilled nursing facility (SNF) provides the necessary daily skilled nursing (IV administration) for a patient who is physically stable but cognitively unsafe for home treatment.
Identifies the correct disposition pathway.

Key Concept

Patients who require prolonged intravenous antibiotics but lack the cognitive capacity and caregiver support to safely manage outpatient parenteral antimicrobial therapy (OPAT) at home should be transitioned to a skilled nursing facility.
Question 1358Question →

A 50-year-old man comes to the clinic to establish care. He has not been evaluated by a healthcare provider in 15 years and has not received any routine medical care or screenings during this time. He generally feels well and takes no medications. He smokes 1 pack of cigarettes daily for the past 30 years and drinks 2 to 3 alcoholic beverages on weekends. He is sexually active with men and uses condoms inconsistently. His BMI is 25 kg/m². Vital signs are within normal limits. Physical examination reveals no abnormalities.

Which of the following preventive interventions are indicated for this patient at this visit? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Annual low-dose computed tomography of the chest; Screening colonoscopy

Answer

Annual low-dose computed tomography of the chest and screening colonoscopy
The correct interventions are annual low-dose computed tomography (LDCT) of the chest and screening colonoscopy. According to current USPSTF guidelines, adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years require annual lung cancer screening with LDCT. This patient is 50 years old with a 30 pack-year history, making him an ideal candidate. Additionally, colorectal cancer screening is recommended for average-risk adults beginning at age 45. Since the patient has not received any medical care in 15 years, he is overdue for a screening colonoscopy.

Step-by-Step Solution

1
Analyze patient demographics and health history.
The patient is a 50-year-old male with a 30 pack-year smoking history who has not received medical care in 15 years.
Preventive screening interventions are strictly guided by age, biological sex, exposure history, and past screening dates.
2
Apply evidence-based guidelines for a 50-year-old male current smoker.
Lung cancer screening is indicated due to age (50) and pack-year history (>20). Colorectal cancer screening is indicated as it starts at age 45 and the patient is unscreened.
Identifying interventions that are currently indicated based on USPSTF guidelines.
3
Evaluate remaining options against current age cutoffs and indications.
Abdominal aortic aneurysm screening is for ages 65-75. HPV vaccination is not recommended after age 45. Dual-energy x-ray absorptiometry is not routinely indicated for men.
Ruling out distractors involving incorrect start/stop ages or unindicated tests.

Key Concept

Age-appropriate and risk-based preventive screening guidelines for adults
Question 1359Question →

A 28-year-old man is brought to the emergency department by emergency medical services 15 minutes after sustaining a stab wound to the left chest during an altercation. The wound is located at the left 5th intercostal space, just medial to the midclavicular line. On arrival, he is lethargic but responsive to painful stimuli. His temperature is 36.8°C (98.2°F), blood pressure is 76/40 mmHg, pulse is 132/min, and respirations are 26/min. Physical examination reveals distended jugular veins. The trachea is midline, and breath sounds are clear and equal bilaterally. Heart sounds are muffled. Which of the following procedural and management interventions are immediately indicated for this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Performance of a bedside focused assessment with sonography in trauma (FAST) examination; Immediate transfer to the operating room for surgical exploration

Answer

The indicated interventions are performing a bedside focused assessment with sonography in trauma (FAST) examination and immediately transferring the patient to the operating room for surgical exploration.
The correct interventions focus on rapid, non-invasive confirmation of the diagnosis and definitive surgical repair. A bedside FAST examination is the standard of care for rapidly identifying pericardial effusion in an unstable trauma patient. Once tamponade is confirmed in the setting of penetrating trauma, immediate surgical exploration (usually via sternotomy or thoracotomy) is mandatory to evacuate the blood and repair the myocardial defect.

Step-by-Step Solution

1
Analyze the patient's mechanism of injury and vital signs.
The patient has a penetrating injury in the 'cardiac box' and is hemodynamically unstable (hypotensive, tachycardic).
Identifying the severity of shock guides the urgency of interventions and rules out time-consuming diagnostic tests.
2
Correlate physical examination findings to formulate the primary diagnosis.
The presence of Beck's triad (hypotension, distended jugular veins, muffled heart sounds) alongside equal breath sounds and a midline trachea points to acute cardiac tamponade, not a tension pneumothorax.
Accurate clinical diagnosis differentiates between competing life-threatening thoracic emergencies.
3
Determine the appropriate diagnostic and therapeutic interventions.
A bedside FAST exam should be performed immediately to confirm pericardial fluid, followed by urgent transfer to the operating room for definitive surgical repair.
Unstable patients require interventions that can be performed at the bedside (FAST) and definitive anatomical correction (surgery).
4
Identify and avoid contraindicated actions.
Do not intubate with positive pressure before decompression, and do not send the patient to the CT scanner.
Positive pressure ventilation severely impairs right heart filling in tamponade, and CT imaging delays life-saving surgery in an unstable patient.

Key Concept

The immediate management of penetrating cardiac trauma with tamponade requires rapid bedside diagnosis via a FAST exam and definitive surgical exploration, while strictly avoiding interventions that decrease venous return (like positive pressure ventilation) or delay definitive care (like CT imaging).
Question 1360Question →

A 7171-year-old woman presents to her primary care physician for a scheduled medication management visit. She has a documented history of severe postmenopausal osteoporosis, which was complicated by a painful L2L2 vertebral compression fracture two years ago. At that time, a dual-energy x-ray absorptiometry (DEXA) scan revealed a T-score of −3.5-3.5 at the lumbar spine, and she was subsequently initiated on daily subcutaneous teriparatide therapy. She has been fully compliant with the medication and reports no new bone pain, back pain, or falls. Today marks exactly 2424 months of continuous teriparatide treatment.

Current laboratory studies:
Calcium: 9.5 mg/dL9.5 \text{ mg/dL}
Phosphorus: 3.6 mg/dL3.6 \text{ mg/dL}
Creatinine: 0.8 mg/dL0.8 \text{ mg/dL}
Alkaline phosphatase: 115 U/L115 \text{ U/L}
2525-hydroxyvitamin D: 45 ng/mL45 \text{ ng/mL}

A repeat DEXA scan performed this week demonstrates a T-score of −2.3-2.3 at the lumbar spine and −2.5-2.5 at the total hip.

Which of the following is the most appropriate next step in the management of this patient's osteoporosis?

Show answer & explanation

Answer: Discontinue teriparatide and initiate oral alendronate therapy

Answer

The patient should have teriparatide discontinued and immediately begin an antiresorptive agent, such as oral alendronate, to preserve her bone mineral density.
The correct course of action is to stop the anabolic agent and immediately begin an antiresorptive agent. Teriparatide is a recombinant fragment of human parathyroid hormone that powerfully stimulates bone formation. However, its use is strictly capped at a cumulative lifetime duration of 24 months. Furthermore, because teriparatide does not embed into the bone matrix, its discontinuation triggers an accelerated phase of bone resorption. To preserve the bone architecture and density gained during the 24-month anabolic window, clinical guidelines mandate sequential therapy with a potent antiresorptive medication, such as a bisphosphonate (e.g., alendronate) or denosumab.

Step-by-Step Solution

1
Evaluate the current duration and status of the patient's pharmacological therapy.
The patient has completed exactly 24 months of teriparatide, which is the maximum lifetime duration recommended.
Teriparatide (a parathyroid hormone analog) must be stopped at 24 months due to long-term safety concerns (e.g., theoretical osteosarcoma risk) and lack of efficacy data beyond this timeframe.
2
Determine the physiologic consequence of stopping the current medication.
Unlike bisphosphonates, anabolic agents do not persist in the bone matrix. Stopping teriparatide results in a rapid decline in bone mineral density (BMD).
Withdrawal of the anabolic stimulus leads to accelerated osteoclast-mediated bone resorption.
3
Select the appropriate sequential pharmacological intervention.
Initiate an antiresorptive agent (such as a bisphosphonate or denosumab).
Antiresorptive therapy must follow anabolic therapy to lock in and consolidate the substantial BMD gains achieved over the preceding two years.

Key Concept

Patients completing a 2-year course of an anabolic agent (e.g., teriparatide) must be sequentially transitioned to an antiresorptive agent (e.g., alendronate or denosumab) to prevent rapid bone loss and maintain fracture risk reduction.
PreviousPage 68 / 104Next